We are pleased to announce a seminar for medical institutions to provide the latest information on treatments using deciduous tooth pulp stem cell culture supernatant (SGF). Our affiliated medical facilities have accumulated a significant track record since 2016, with approximately 7,000 cases (including cosmetic dermatology, around 12,000 cases), along with numerous effective case studies and precise data verification through collaborative research with academia.
We are currently able to obtain data that suggests the effectiveness of our treatment in the context of COVID-19 infection. This information will be presented by Dr. Shoji Koga, a special advisor to the Solaria Clinic Group, in a lecture. Given the current situation with COVID-19, we will limit on-site attendance to approximately 30 people and provide the option to participate in the seminar via Zoom. There will also be a Q&A session in the latter part, so we hope you will join us and find valuable insights into the latest developments in deciduous tooth pulp stem cell culture supernatant (SGF) and exosome therapy.
【Event Details】
□ Date
Novembe 29, 2021 (Monday)
□ Time
19:00 PM – 20:30 PM (Registration: 18:30 PM)
□ Venue
To be conducted via Zoom
(Additional details will be provided after registration.)
□ Speaker
Dr. Shoji Koga, Special Advisor to Solaria Clinic Group, responsible for Restorative Medicine
□ Participation Fee
Free (Limited to the first 30 attendees)
*This seminar is exclusively for physicians who Management medical facilities.
【Seminar Agenda】
・ Latest Information on Deciduous Tooth Pulp Stem Cell Culture Supernatant (SGF)
・ Treatment Case Studies and Research Achievements
・Effectiveness of SGF against the novel coronavirus.
・Q＆A
【Registration】
To apply via email, send your request to: info@solaria.tokyo
For inquiries and phone registrations, please contact:Solaria Clinic Group SGF Office at 03-5809-7979
Organized by: Solaria Clinic Group and Panajee Co., Ltd.
Supported by: Social Welfare Corporation Jinseikai Edogawa Hospital, Japan Society for Pioneering Regenerative Medicine, and others.
